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T~s study describes the presence in sera from pa-
tients with linear IgA bullous dermatosis (LABD) of 
IgA antibodies specific for 230,. or 180-kDa epidermal 
antigens. Of 11 patients' sera with IgA antibodies 
reactive with the epidertnal antigens obtained from 
cultured keratinocytes, 6 sera recognized the 230-
kDa antigen and co-migrated with the polypeptide 
recognized by a human monoclonal antibody against 
the 230-kDa bullous pemphigoid antigen (BPAgl). 
Five sera recognized the 180-kDa antigen and co-
migrated with the polypeptide stained by a poly-
clonal antibody to the 180-kDa bullous pemphigoid 
antigen (BPAg2). None of these LABD sera contained 
IgG antibodies reactive with the basement membrane 
zone antigens and none labeled a 97-kDa epidermal 
antigen or a 290-kDa dermal antigen. Immunoaffin-
C onsiderable efforts have been devoted to the immu-nocherl1ical charactenzatIon and ultrastructural lo -calization of the linear IgA bullous dermatosis (LABD) antigen(s). These studies have yielded dis-. cordant results suggesti!.1g that the disease is h e ter-
ogeneous. IgA deposits !lave b een found within the laHlina lucida 
(Ishiko el Ill, 1996), within the hemidesmosomal plaques and the 
adjacent lamina lucida (Haftek ct 111, 1994), below the lamina densa 
(Bhogal et 111,1987), or at both sides of the lamina densa (Prost ct 111, 
1989) . A 97-kDa antigen obtained from the epidermal and dermal 
extracts (Zone ct al , 1990) and a 285-kDa dermal antigen (Wojn-
arowska et ai, 1991) have been claimed to be tbe target antigen in 
LABD. All sera, however, from the p a tients with LABD with 
demonstrable anti-basement membrane antibodies do not recog-
nize the 97-kDa or 285-kDa antigens (Dmochowski c/ ai, 1993) . In 
this regard, we investigated tbe antigenic specificity of those LABD 
sera that remained negative on protein Iysates derived from the 
epidermal wash of ethylenediamine tetraacetic acid (EDTA) split 
skin (ESS; for the 97-kDa component) or from the dermal side of 
salt-split skin (SSS; for the 285-kDa component) . 
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EDTA-split skin; LAnD, linear IgA bullous dermatosis; SSS, NaCI-split 
skin. 
ity-purified IgA antibodies from the 230 kDa band 
further reacted with the epidermal side of tile skin. 
basement membrane zone. Epitope mapping with 
rBP55, a fusion protein containing th~ C-ter.minal 
end of BP~gl, suggested that the major antigenic 
epitopes for LABD and BP antibodies on the 230-kDa 
antigen a.re different. Only one serum with Ig~ anti~ 
bodies was found to label rBP55, contrasting with 
nine of ten BP sera reacting with this protein. OUl' 
study demonstrates the presence of an exclusive Ig.l\ 
response against the 230- or 180-kDa antigens in a 
subset of patients with LABD. Key words: alltoillllll111Ii, 
ty/sllbepidermal l",llolls diseases/bullous pemplligoidllillear 
IgA disease/autoalltigen. J Invest Del'tllatol 108:854-858J 
1997 
We show that a subset of LABD patients has exclusively IgA 
antibodies that selectively bind to the 180- or 230-kDa epidermal 
antigens in an extract of cultured human keratinocyt~s in inUTIu-
noblot assays. These sera have no IgA or IgG reactivity against the 
other epidermal or demla] antigens, 1,amely, the 97-kDa antigen 
(Zone et ai, 1990) or the 290-kDa epidermolysis bullosa acquisita 
(EBA) antigen (Woodley e/ nl, 1984) . 
MATEIUALS AND METHODS 
Patients and Controls Eleven sera from patients with LAnD that were 
negative on epidermal wash ofESS (for the 97-kDa component) and demlal 
extract were uscd. The patients fulfilled thc following critcria: (i) clinical 
features suggestive of LAnD, i.e., vesiculobullous skin lesions over the 
trunk, iJ1l]cr thigh, and pelvic rcgion with dinical response to dapsone; the 
ocular Jnucosa was also involved in two of the patients but there '\vas no 
scarring; (ii) histologically subepidermal split with predominant infiltration 
nf neutrophils in addition to eosinophils and Iyn!phocytes; and (iii) by direct 
immunofluorescence, only ;11 ,,;/10 li near IgA deposits at thc bascment 
membrane zone (BMZ) (no patient had IgG at the BMZ) . Control sera 
included: (i) 12 sera from patients with bulbous pemphigoid (BP), reacting 
with th," 23Q-kDa bullous pemphigoid antigen (BPAgl; N = 10) or 180 
kDa-bullous pemphigoiq antigen (BPAg2; N = 2); (ii) one EBA serun, 
reacting with the 290-kDa antigcn (type VII co ll agcn); (iii) one LAnD 
serum with reactivity to thc 97-kDa band (Haftek et ai , 1994); (iv) four sera 
of patients with pemphigus vulgaris reacting with the 130-kDa antigen; (v) 
II sera of patients with other inflammatory skin di~ordcrs; and (vi) five sera 
from normal individuals. The fo!lowing antibodies were used in tlus study: 
a human monoclonal antibody (MoAb) to BPAgl (Peyron et ai, 1994) , a 
guinea pig polyclonal antibody to the C-terminal part ofBPAg1 (Gaucher_ 
and et ai, 1995), a rabbit polyclonal antibody to cnUagen type IV (Institute 
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Table I. Immunopathologic Profile of the Patients With Linear IgA Bullous Dermatosis· 
Immunofluorescence 
Indirect IF Immul1oblot 19A Detection" 
Patient Direct 
No. fF IgA" Titer Cultured Keratinocytes Epidennal Wash Defina} Extracts 
tlF- 4 IgA E 1 :160 230 leDa Neg. Neg. 
2/F- 21 IgA E 1:320 230 leD. Neg. Neg. 
3/M-38 IgA E 1:320 230 kD" Neg. Neg. 
4/M-47 19A E 1:80 230 leDa Neg. Neg. 
5/F-75 IgA E t:80 230 kDa Neg. Neg. 
6/F-75 19A E 1:40 230 leDa Neg. Neg. 
7/F-4 IgA E 1:80 180 leDa Neg. Neg. 
8/F-50 IgA E 1:40 180 leDa Neg. Neg. 
9/M-65 IgA E 1:40 180 leDa Neg. Neg. 
IO/M-68 IgA E 1:80 180 leDa Neg. Neg. 
I1/F-70 egA E 1:40 180 leDa Neg. Neg. 
II Peri bullous Jesions were used for exploring: the BMZ imnlufloglobuUn deposits and (he patients' Sera for determining the specific reactivity of circu.lating antibodies ngtlins( the 
epidermal or dermal side of SSS by immunofluorescence (IF) microscopy w ith secondary anti-IgG and anti-lgA antibodies. The antigen $pccificicy of the patients' sera was 
detennined by the technique of we,tern blot analysis using different antigenic sources: cu/tured kcratinocyccs (for the '180- alld 230-kDa J3p a"tigens), epidermal wash ofESS (for 
the 97-kD o\ antigen), and dermal c"cr;lCCS ([or the 290-kD. EBA ;Intigen). 
~ All results for in1l'nul1ofiuorcscencc and inullunoblor a.ssay wirh 19G were negative . Neg., negative ; E. epidermal. 
Pasteur, Lyon, Fr:lnce), a eommerciaUy available mouse MoAb to coIlagen 
type VU (Serotec, Oxford, UK), and various secondar), antibodies [a 
biotinylated goat anti-human [gA (a-chain specific) antibody (A111crsham, 
Buckingbamshire, UK), a goat anti-human IgG (Amersham, Buckingham-
!hire , illZ), a fluorescein isothiocyanatc-colijugated rabbit allti-human IgG 
(Dako, Glostrup, Denmark), and a fluorescein isothiocyanate-colyugated 
rabbit anti-human [gA (Dako, Glostrup, Denmark)]. 
DennaI-Epidermal Separation Strips (3.0 X 2.0 Clll) of normal human 
!kin were obtained from women undergoing mammoplasty and washed in 
pbosphate-buffered saline (PBS: 0.126 M NaCl, 0.008 M N~\2HP04' and 
0.002 M KH2PO,,, pH 7.2). Dermal-epidermal separation was performed by 
tWO methods: (i) SSS used 1.0 M NaCI as previously described (Ghohestani 
d aI, 1996b); briefl)" the skin pieces were incubated with a 1 M NaCI 
solution containing 10 111M phen),lmethylsulfonyl fluoride (PMSF) at 4°C 
for 72 h. (ii) ESS used 20 mM EDTA and 10 mM PMSF in PBS as described 
by Zone et al (1990). The MoAb to BPAgl labeled the epidermal side, 
wbereas the antibodies to types IV and VII collagen labeled the dermal side 
of bwnan SSS/ESS. 
Inununafluoresccnce Microscopy Circulating anti-BMZ anti bodies 
were detected by standard immunofluorescence (Ghohestani et aI, 1996b) 
performed on 4-/1-111 cryostat sections of normal human SSS or skin of a 
patient with generalized atrophic benign epiderololysis bullos. with defect 
in BPAg2 expression. The sections were incubated for 30 min at 20·C with 
the seru.m studied (diluted 1 :20 in PBS), then washed with PBS, and 
incubated for 30 miu with filtered fluotescein isotluocyanate-conjugated 
rabbit anti-hlllUal1 IgG or IgA antibodies diluted 1:40 in PBS. 
Protein Lysates To ellsure that all the recently described skin antigens 
were present in our lysates, we used the following antigenic preparation 
promeo1s: 
Epidermal Proleills Epidermal antigens werc obtained from two sources: (i) 
numan cultured keratinocytes (Ghohestani el ai, 1996d), from wluch the 
proteins were extracted after incubation for 30 min at 4°C with an 
extraction buffer of 65 rnM Tris{hydroi,'l11ethyl)aminomethane hydrochlo-
ride, pH 7.8, containing 2% SDS, 5% 2-mcrcaptoethanol, 100 /1-M EDTA, 
200 iJ-M phenylmetbylsLllfoLlyl fluoride, 1 /1-M leupeptill, and 1 J..LM pep-
Starin ; or {iii cpidermal wash of ESS (which is specifically developed for 
detection of the 97-kDa band by Zone et al (1990) ahd Haftek ef al (1994). 
Briefly, th e epidermis was s~parated from the dermis after" 72-h incubation 
with 20 111M EDTA and. 10 Il1M PMSF at 4°C. T he epidermis was washed 
for three 15-min periods in PBS, and the wash solutions were pooled and 
dialyzed against water. 
Demlat Proteills After dennal-epidermal separation by either 1 M NaGI or 
20 mM EDTA, the epidennis waS peeled away from the dermis. Dermal 
prote'ins were then extracted with 8 M urea alld 0.3 M 2-mercaptoetllanol 
in 25 mM Tris(hydroxymethyl)aminomethane buffer, pH 7.8, contailling 10 
mM PMSF and incubated for 45 min on an agitator at 4°C. The tissue 
remnants were removed by centrifugarion ;It 13,000 X S for 25 min at 4°C. 
The supernatants were stored at -20cC until nsed.. 
BPAgl Fusion Protein (rBP55) A segment ofa human cDNA (1.5 kb) 
encoding for the C-terminal part of the BPAgl was snbcloned into the 
expression vector pGEX-3X (Pbal11lacia Biotech , Orasy, Frallce). Tbe 
resulting recombinant protein encoded by pGEX-3X was then expressed in 
Escllerichia coli (strain DHSa) and purified as desclibed previously (Gauch-
erand et aI, 1995). 
SDS-PAGE and Immunoblot Analysis Epidermal and dennal proteins 
were separated by SDS-PAGE in a 6% polyacrylamide gel under reducing 
conditions. rBP55 was used On a 10% polyacryhrmide gel. The proteins were 
electrophoreticaIly trallsferred onto nitrocellulose membranes. Nitrocellu-
lose strips were then sequentially incubated with (i) 5% dried milk in 10 mM 
Tris(hydroxymeth),l)amillomethane hyd.rochloride and 140 mM NaCI. pH 
7.4, for 1 h at 37°C or overnight at 4°C; (ii) a 1:100 dilution of each Serum 
in 5% dried milk in 10 mM Tris(hydroxymetbyl)nl11inOl11ethane hydrochlo-
ride and 140 111M NaCI, pH 7.4, for 1 hat 37"C; (iii) a 1:200 dilution ofa 
biotin),lated goat anti-hulllan IgA (a-chain speci.fi c) a.ntibody or anti-human 
IgG secondar), antibodies in 5% dried milk in 10 mM Tris(hydro},:ymethyl) 
aminomethane hydrochloride alld 140 mM NaCI, pH 7.4, for 30 min at 
room temperature (anti-gui.nea pig or mouse cOlyug<rtes were used for 
guinea pig polyclonal antibodies and mouse MoAb , respectively); and (iv) a 
1 :3000 dilution of streptavidin-alkaline phosphatase substrate solution (A.m-
crsham, Bnckinghamshire, UK). T he reaction was revealed with 5-brol11o-
4-cb.loro-3-indolyl phosphatelnitro blue tetraZOlil1111 b\lffered substrate 
tablets (Sigma, St. Louis, MO). Reaction times for all lanes of individual 
blots were identical. Intervening washes were performed with 10 mM TBS 
Tris(hydro"-1'Illeu1yl)aminoll1ethane hydrQchloride and 140 mM NaCl, pH 
7.4, and 0.1°1t, Tween 20. 
Immunofluorescence of Nitrocellulose Immunoaffini ty-purified 
Antibodies T he protein bands transferred onto lutroceHulose sheets were 
used as immllnoaffinity substrates to puri.ty ,ultibodies directed against the 
protein of interest as described (Olmsted, 1981) . Mter transferrillg the 
proteins of ep idermal extracts onto a nitroceIlulosc membrane, vertical 
l'Ules from both sides ofche membrane were excised and imJllunochemically 
stained with sera to identify the band of interest. Horizontal strips of 
nitrocellulose containing the antigen of interes t were then excised, and 
serum was applied at a 1:5 dilution in PBS for 2 b. After washing in 
PBS-TweCJl 20, the antibodies were eluted in 20 mM sodium citrate. pH 
3.2, and 0.04% Tween 20 for 3 min at 37· C, and then immediately 
neutralized Witll 2 M Tris(h),droxymethyl)aniinomethane hydrochloride, 
pH 7.5. The SO[ution was then dia.1yzed against the buffer. concentrated, 'lIld 
used in inimunofluorescence. 
R.ESULTS 
The 230- and 180-kDa Epidermal A~tigens Are Recognized 
Exclusively by IgA Anti-BMZ Antibodies Immunofluores-
cerice microscopy displayed exclusively IgA 3nti-BMZ antibodies 
in aU the 11 LABD sera that se lectively labeled the epidermal side 
of SSS (Table 1). All 11 LABD sera contained exclusively JgA 
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Figure 1. IgA antibodies from a subset of patients with LAnD label 
230- or 180-kDa epidermal antigens. We used protein Iysates obtained 
from two different sources, human cultu red kcratinocyte extracts and 
epidermal wash (for detection of the 97-kDa band) . T he proteins were 
separated by SDS-PAGE in a 6'X, gel, transferred onto nitrocellulose 
membranes, and incubated with the patients' sera at a 1 :100 dilution for 1 h 
at 34 °C. The specific reactivity of the serum against the blotted proteins was 
further revealed by secondary anti-IgA or -lgG antibodies. (a) C ultured 
keratinocyte extracts. Extracts were prepared from normal human cultured 
keratinocytes. The 230-kDa BPAgl and 180-kDa 13PAg2 are labeled by a 
MoAb to BPAg1 and by a polydonal antibody to BPAg2 (Ialles 1 and 2, 
respectively) , and a pemphigus vulgaris serum stains the l30-kDa antigen 
(desmoglein 3; lalle 3). Serum from a normal individual, revealed by 
anti-lgA (Ialle 4) conjugates. remains unreactive. Sera from patients (re-
vea led by 'lI1ti-lgA conj ugates) shown in lalles 5-10 label the 230-kDa 
BPAg1 and shown in In "" 11 label the 180-kDa BPAg2. (b) EpidennaI wash. 
Tlus wash was obtained from the skin specimens treated with 20 mM EOTA 
instead of 1 M NaCI '1I1d allows us to detect the 97-kDa band specifically. 
A control serum with IgA antibodies to the 97-kDa antigen labels a band 
with the equivalent moleclliar weight (lalle 3). Serum fi:om a normal 
individual (revealed with an anti-lgA conjugate) is completely unreactive 
(Inll" 2). A BP serum also contains IgG antibodies against the 97-kDa band 
(Lalle 1). The LABD sera with IgA reactivity against the BP antigens do not 
label the 97-kOa band (Inll es 4 and 5). 
antibodies (and not IgG antibodies) reactive with the epidermal 
antigens obta ined from the cultured keratinocytes (Fig in): six sera 
identified the 230-kDa antigen and five other sera identified the 
180-kDa antigen. T hese bands co-migrated with the BPAgl and 
BPAg2 as identified by an anti-BPAgl MoAb and a polyclonal 
anti-BPAg2 antibody, respectively. lmmunoaitinity-purified anti-
230-kDa TgA antibodies further labeled the skin BMZ and bound to 
the epidermal side of SSS. Moreover, like the control anti-BPAg2 
polycional antibody, anti-BPAg2 IgA antibodies from our patients' 
sera did not label, by immunofluorescence microscopy, the skin 
basement membrane of a patient with gen era lized atrophic benigtl 
epidermolysis bullosa with a defect in BPAg2 expression . None of 
the negative control sera, including those obtained from nomla] 
individuals and the patients with pemphigus vu lgaris, epidermolysis 
bullosa acquisita, or other non bullous inflammatory dennatoses 
labeled the 230- o r 180- kDa antigens. 
None of our LABD sera contained IgA or IgG antibodies against 
the 97-kDa antigen on the epidermal wash prepared from ESS (Fig 
lb) o r c ultured keratinocytes, but tlus 97-kDa band was staine d by 
a control LABD serum containing IgA antibodies to the 97-kDa 
antigen (Fig lb, lalle 3). Two of our control BP sera with 
circulating IgG antibodies to BPAg2 also contained IgG anti-97-
kDa antibodies. 
None of the sera contained IgA antibodies to the 255- to 
285-kDa dermal antigen, but a control serum jabe led the 290-kDa 
EBA antigen (Fig 2). 
LAnD Epitopes on the 230-kDa Antigen Are Different from 
the BP Epitopes To further characterize the epitopes recog-
nized by LABD antibodies on the 230-kDa antigen, we assessed 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
EBA I c I LAnD I 
290_ 
2 3 4 
Figure 2. Circulating antibodies from the LAnD patients do not 
react with dermal antigens. The derma.l part of normal human skin was 
separ"ted from the epidermis aftcr incubation with 1 M NaCI containing 50 
/.I.M PMSF "nd 0.1 M EDTA for 72 h at 4°C and was used for protein 
extraction. The 290-kDa EBA antigen is labeled by IgG antibodies from an 
EBA serum (Inll" 1), but sera from our patients do not cont"in IgA or IgG 
antibodies reactive with the dermal antigens (/nll's 3 and 4). Serum from a 
normal individual remains unreactive (1,,"" 2). 
IgA reactIvIty of our sera on rBP55, a BPAgl fusion protein 
containing the C-terminal end of the protein. Only o ne of sb.; 
LABD sera with IgA antibodies to 230-kDa antigen labeled the 
rBP55 (Fig 3 , lalle 5); by contrast, nine of ten BP sera with IgG 
antibodies to the BPAgl mapped to rBP55 , demonstrating that the 
majority of our LABD sera did not recognize epitopes specific for 
BP antibodies. None of the negative control sera, including tho e 
obtained fi'om normal individuals, pemphigus vulgaris patients, and 
BP sera with antibodies to the BPAg2 labeled this protein. A guinea 
pig polyclonal antibody raised against the rBP55 stained the 55-kDa 
band. 
DISCUSSION 
In this study we have demonstrated the antigenic specificity ofIgA 
autoantibodies in a subset of patients with LABD for the 180- Or 
230-kDa epidermal antigens. When we llsed anti-IgA secondary 
2 3 4 5 
Figure 3. IgA antibodies against the 230-kDa epidermal antigen 
are not primarily directed against the C-terminal end of the 
BPAg1. To furtber characterize the BPAgl epitopcs recognized by IgA 
autoantibodies, we evaluated IgA reactivity of our LABD sera against the 
rBP55, a BPAg1 fusion protein containing the C-tcrrninal end of the protein 
by immunoblot assay. rBP55 contains the major antigenic epitopes for Bp 
antibodies. Most of Ollr LABO sera f.,i l to react with dus protein. A guinea 
pig polyclona l IgG antibody ra.ised to BPAgl labels the rBP55 (Inlle 1): 
serum from a normal individual does not contain IgG or IgA antibodi~ 
against rBP55 (fnlles 2 and 3). On.ly one serum with 19A antibodies to th 
230-kDa antigen labels rBP55 (Inlle 5). the other LAJ3D sera being negatil'e 
(Iallc 4). 
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antibodies (and not anti-IgG antibodies) by immunofluorescence 
microscopy on SSS, all 11 sera labeled the epidermal side of SSS, 
indicating that IgA autoantibodies are directed primarily toward an 
antigen within or above the lamina luci.da. When we further 
evaluated the IgA reactivity of these sera widl the epidermal 
extracts obtaining from cultured kerati1lOcytes, six sera labeled ilie 
230-kDa antigen and five sera labeled the 180-kDa antigens. These 
bands co-migrated with the 230-kDa BPAg1 and 180-kDa BPAg2 
identified by a human MoAb to BPAg1 and a polyclonal antibody 
to the 180-kDa component, respectively. Furthermore, immwlO-
affinity-purified IgA antibodies fi'om the 230-kDa band labeled the 
epidernnl side of SSS by immunofluorescence microscopy, simi-
larly to anti-BPAg1 antibodies, and like polyclonal anti-BPAg2 IgG 
antibodies, anti-BPAg2 IgA antibodies from our LABD sera d.id not 
label the skin BMZ of a patient with generalized atrophic benign 
epidernlOlysis bullosa with a defect in BPAg2 expression (McGrath 
d al, 1996). 
BPAgl and BPAg2, the major components ofhem.idesmosomes. 
were fust identified by sera of patients suffering from BP (Stanley et 
ai, 1984) . BPAg2 is a transmembrane protein of180 kDa with type 
II orientation (Giudice et ai, 1993), whereas BPAg1 is an intracy-
toplasmic protein of 230 kDa that is homologous in amino acid 
sequence and structure to desmoplakins IIII, the alternatively 
spliced desmosomal plaque proteins (Stanley, 1995). Since the 
230-kDa BP is an intracellular molecule and the 180-kDa antigen is 
a transmembrane molecule, it has been suggested that anti-BPAg2 
antibodies should represent pathogenic antibodies, whereas anti-
BPAg1 antibodies may represent an epiphenomenon (Stanley, 
1995; Ghohestani et ai, 1996a). Because of the recent demonstration 
that the autoantibodies could penetrate living cells and subsequently 
alter their function, however, ilie idea iliat tlle internal milieu of cells 
is inununologically privileged and caJmot be reached by autoantibodies 
is likely to be abaJldoned (Alarcon-Segovia e/ ai, 1996). 
BP Ag1 and BPAg2 are recognized by the sera of the patients with 
distinctly different clinical disorders. Sera from patients with cica-
tricial pemphigoid and pemphigoid gestationis contain IgG antibod-
ies primarily against the 180-kDa BPAg2 but also ill few cases 
against the 230-kDa BPAg1 (Bernard e/ ai, 1992; Giudice et ai, 
1993; Ghohestani et ai, 1996c). A 168-kDa mucosal antigen and the 
cx3 and {33 chains of lam.inin-5 are also recognized by a subset of 
patients with cicatricial pemphigoid (Kirtschig e/ ai, 1995; Ghohes-
tani et ai, 1996d).1 Although a common epitope on BPAg2 is 
recognized by about 60% of BP and pemphigoid gestationis sera 
(Giudice et ai, 1993), the major epitope on BPAg1 for BP has been 
shown not to be recognized in a case of pemphigoid gestationis 
with anti-BPAg1 IgG antibodies (Ghohestani et ai, 1996c). Recent 
studies have further suggested that the epitope(s) recognizing by 
the cicatricial pemphigoid and BP sera on BPAg2 are not the same 
(Balding ct ai, 1996). 
Our data also suggest tllat the reactive sites of LABD IgA 
antibodies and BP IgG antibod.ies on BPAg1 are distinct. The 
C-terrninal end ofBPAgl was found to contain the major antigenic 
epitopes for BP autoantibodies (Tanaka ct til, 1990; Gaucherand et 
ai, 1995), because 92% of sera with anti-BPAg1 antibodies map 
within this region and label rBP55. rBP55 is a recombi.nant protein 
encoded by a cDNA encompassing the C-terminal part ofBPAg1 
(Gaucherand et ai, 1995). By contrast, for the LABD sera, only one 
serum recognized the C-terminal part ofBPAg1, indicating that dle 
major antigenic epitopes for LABD and BP antibodies are not 
co-localized within the C-terminal end of the protein. Alterna-
tively, IgA antibodies may be directed either against the N - terminal 
part of the native BPAg1 or against a conformational carbohydrate 
epitope of the protein. These data further support the concept that 
there are multiple B-cell epitopes on the BPAg1 (Tanaka et ai, 1990; 
Peyron cl til, 1994; Gaucherand el ai, 1995) . Moreover, tlus finding 
may explain the presence of two different isotypic antibod.ies 
I Ghohestani RF, Rousselle P, Nicolas JF, Claudy AL: Cl' and (3 subunits 
of lruninin-S arc targe t antigens in a subset of patients \vith cicatricial 
pemphigoid. ) IlIlIest Der/llntol 106:846, 1996 (abstr). 
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(IgA/ lgG) against the sanle antigen; the two epitopes may stimulate 
the immune system by different pathways, lead.ing to differential 
secretion of transfornung grOWtll factor {3 and interleukin-5, ilie 
cytokines with important roles in IgA class switching (Esser and 
Radbruch, 1990). 
Our data provide further evidence for the concept that LABD 
encompasses a group of bullous d.isorders sharing an IgA response 
to different BMZ antigens, i.e. , the BP aJltigens of1 80 aJld 230 kDa, 
a 97- to 120-kDa antigen, and collagen rype VII (Provost et ai, 
1979; Kanitakis et ai, 1994; Zambruno et ai , 1994; Berard et ai, 1996; 
Hashimoto et ai, 1996; Marinkowich et ai, 1996). When an 
epidernlal wash ofESS (enriched for the 97-kDa band) was used for 
in1.munoblot assay, none of our sera with IgA reactiviry to the 180-
or 230-kDa antigen reacted with the 97-kDa band, but a control 
LABD serum labeled this band. Tlus 97-kDa band was also stained 
by IgG aJltibod.ies from two of the 12 BP control sera tested on an 
epidermal wash ofESS. Tlus finding, in concert with the previous 
ones (Labib ct ai, 1986; Dmochowski ct ai, 1993) , suggests that the 
97-kDa band is not strictly specific for LABD antibodies , because 
some BP antibodies also label it, altllough the immunoglobulin 
classes are different (lgA/ lgG). Circulating IgG antibodies (in 
addition to IgA) against the 97-kDa antigen have been also detected 
in a patient with ilie clilucal features ofLABD (Chan et ai, 1995 ). 
In contrast to BP, in which dle main inflanmlatory cells are 
eosinophils, LABD lesions show a predominant neutrophil infiltra-
tion (Chorzelski e/ til, 1979). Neutrophils bear IgA receptors 
(Hendrix et ai, 1990) , and once IgA has bound to the components 
of hemidesmosomes, it could function as ligand for neutrophil 
adherence and activation (Niwa e/ til, 1987) . Further investigations 
are underway in our laboratory to explore the potential ill "h'D 
pathogenic effects ofIgA autoantibodies. 
Our study demonstra tes the presence of an IgA-specific immune 
response against the BP antigens in LABD. Accordingly, we 
propose a new classification of LABD on the bas is of involved 
antigens. Tlus approach offers a more definitive view ofJgA bullous 
dermatoses by focusing on more homogeneous patient groups. 
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